All news

Truist upgrades Edwards Lifesciences to strong-buy

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Truist Financial upgraded Edwards Lifesciences (NYSE:EW) from hold to strong-buy, with an analyst target of

Read original source

EW company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.